Trademark

A Trademark Information

Number:
2660848
Words:
A
Images:

Kind:
Figurative
Status group:
PENDING
Status code:
Published
Status detail:
Awaiting examination
Priority date:
09 Jun 2026
Lodgement date:
09 Jun 2026
Filing date:
09 Jun 2026
Indexing constituents:
A, LTR, #
Class:
1,5,9,10,40,42,44
Mark categories:
Trademark
Last status check:
2026-06-20 02:05:59
Goods and services:
1) Class: 1
Description: Chemicals for use in industry and science, chemical preparations for use in the manufacture of pharmaceuticals, biological preparations for use in industry and science, reagents for research, laboratory and scientific use, chemical, biochemical, and biological reagents for scientific purposes, nucleic acids for scientific and laboratory purposes, lipids for use in industry and manufacture, polymers and polymeric additives for use in the manufacture of pharmaceutical preparations, peptide substrates for scientific purposes, amino acids for scientific purposes, chemicals for use as delivery materials in the manufacture or development of gene therapy, nucleic acid medicines, biologics and molecular therapeutics, including, nucleic acids, plasmids, RNA and DNA constructs, viral and non-viral vectors, lipids, polymers, nanoparticles and peptides
2) Class: 5
Description: Pharmaceuticals, medical and veterinary preparations, dietetic food and substances adapted for medical or veterinary purposes, dietary supplements for human beings and animals, synthetic peptides for pharmaceutical purposes, biological preparations for medical purposes, biological preparations for diagnostic purposes, biological reagents for medical purposes, nucleic acids for medical or veterinary purposes, drug delivery agents, medicines, pharmaceutical preparations and biological preparations for the prevention, diagnosis, management, or treatment of human diseases and for veterinary applications, including nucleic acid therapeutics, gene therapy products, RNA and DNA medicines, pharmaceutical delivery formulations, drug and nucleic acids carrier solutions, viral and non-viral vector-based therapeutics, cell and gene therapeutic preparations, precision medicines designed to modulate gene or protein expression, clinical diagnostic regents, biomaterials in the nature of biological tissues for clinical purposes, reagents for medical use, chemical, biochemical, and biological reagents for medical and pharmaceutical purposes
3) Class: 9
Description: Scientific, research and testing apparatus and instruments, downloadable and recorded software, including artificial intelligence, machine learning, and bioinformatics platforms, for use in the research, design, personalization, optimization, clinical deployment, and monitoring of pharmaceuticals, nucleic acid medicines, gene therapies, and molecular therapeutics, software for processing genomic, transcriptomic, proteomic, metabolomic, clinical, and patient-specific molecular data to inform individualized therapeutic regimens, software for modeling delivery vectors, precision dosing, molecular targeting, and clinical decision support, patient-facing mobile or desktop software applications for personalized treatment management, remote therapeutic monitoring, integration with electronic health records, and digital companion diagnostics, software for medical and therapeutic purposes, sensors, detectors and monitoring instruments
4) Class: 10
Description: Surgical, medical, dental and veterinary apparatus and instruments, medical apparatus and instruments for the delivery, administration, or targeting of nucleic acid therapeutics, gene therapies, molecular medicines, biological drugs and/or personalized therapeutics, surgical and medical devices, namely, injection devices, microneedle arrays, ocular or neurological delivery implants, electroporation devices, and other drug delivery systems, drug delivery devices, empty, infusion and injection devices for administering medicines, sensors for monitoring biological and electronic signals, for medical and veterinary purposes
5) Class: 40
Description: Custom manufacturing services in the field of pharmaceuticals, biologics, nucleic acid therapeutics, viral and non-viral vectors, and molecular medicines, contract manufacturing of biotechnology, gene therapy, precision medicine, and pharmaceutical products, provision of bioprocessing services for pharmaceutical preparations, including formulation, purification, and fill-finish, custom manufacture of pharmaceuticals by pharmaceutical compounders, processing of biopharmaceutical materials for others, custom biomanufacturing of pharmaceuticals, custom manufacturing of pharmaceuticals
6) Class: 42
Description: Scientific and technological services and research and design relating thereto, design and development of computer hardware and software, biotechnology research and development services, pharmaceutical and gene therapy research services, development of nucleic acid medicines, gene editing technologies, biologics, molecular targeting systems, and delivery platforms, software as a service (saas) featuring software for biopharmaceutical development, drug discovery, clinical bioinformatics, and personalized therapeutic modeling, pharmaceutical drug development services, pharmaceutical testing, pharmaceutical product evaluation, provision of scientific research information in the field of pharmaceuticals, laboratory services for the production of pharmaceuticals, laboratory research and analysis, research relating to molecular sciences, including molecular profiling, biological, clinical and medical research and analysis, technical data analysis, contract research services for pharmaceutical development and gene -based therapeutics, design and development of medical technology, clinical research, clinical trials, information, advisory and consultancy services relating to the aforesaid
7) Class: 44
Description: Medical services, medical, healthcare, clinical services, and veterinary services in the field of gene therapy, nucleic acid-based therapeutics, precision medicine, and personalized molecular treatment, administration of pharmaceuticals and gene therapies, patient-specific diagnostic, prognostic, and therapeutic monitoring services in the treatment of patients, provision of medical information relating to molecular and genetic treatments, provision of medical information and consultancy services to improve or optimise treatment plans for patients by integrating personalized genomic data, providing information relating to medicine, medical diagnostic services
History and publication details:
1) Date: 2026-06-12
Display name: Indexing details updated
2) Date: 2026-06-12
Display name: Awaiting examination
3) Date: 2026-06-12
Display name: Word and image indexing completed
4) Date: 2026-06-09
Display name: IP Right Filed correspondence sent
5) Date: 2026-06-09
Display name: IP Right Filed Published
6) Date: 2026-06-09
Display name: Status change to Published
7) Date: 2026-06-09
Display name: Minimum Filing Requirements Considered
8) Date: 2026-06-09
Display name: Status change to Filed
9) Date: 2026-06-09
Display name: Status change to Received
10) Date: 2026-06-09
Display name: Trade mark representation updated
11) Date: 2026-06-09
Display name: Application Received

Owner Information
Owner name:

Owner structured address:
173 Connells Point Road, Connells Point, NSW, AUSTRALIA, Postal Code: 2221

Owner is private:
0

Service Information
Address Abn:
21615894365

Address Acn:
615894365

Address name:

Address structured address:
Level 15 376-390 Collins St, MELBOURNE, VIC, AUSTRALIA, Postal Code: 3000

Address is private:
0
Scroll to Top